BioDrugs

April 2018, Volume 32, Issue 2, pp 137–138 | Cite as

Correction to: Epoetin Biosimilars in the Treatment of Chemotherapy-Induced Anemia: 10 Years’ Experience Gained

• Authors
• Authors and affiliations

• Matti Aapro
• Andriy KrendyukovEmail author
• Martin Schiestl
• Pere Gascón

Correction

First Online: 28 February 2018

• 783 Downloads

Download article PDF

1 Correction to: BioDrugs  https://doi.org/10.1007/s40259-018-0262-9

Figure 1, HX575 column, 5th box down, which previously read “SC HX575 vs. Eprex^®/Erypo^® 417 patients with CKD-related anemia” as shown here,

Open image in new window

should read “SC HX575 417 patients with CKD-related anemia” as shown below.

Open image in new window

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

• Matti Aapro
  • 1
• Andriy Krendyukov
  • 2
  Email author
• Martin Schiestl
  • 3
• Pere Gascón
  • 4

1. 1.Institut Multidisciplinaire d’Oncologie, Clinique de GenolierGenolierSwitzerland
2. 2.Hematology/NephrologySandoz Biopharmaceuticals, HEXAL AGHolzkirchenGermany
3. 3.Sandoz Biopharmaceuticals, Sandoz International GmbHKundlAustria
4. 4.Department of Hematology-Oncology, Hospital Clínic de BarcelonaUniversity of BarcelonaBarcelonaSpain